Abbott agrees to DOJ settlement over 2022 infant formula recall - ABT News | RalliesAbbott agrees to DOJ settlement over 2022 infant formula recall
A
ABT• Abbott reaches agreement with Justice Department
- Abbott Laboratories reached an agreement with the Department of Justice to resolve claims relating to the 2022 infant formula recall.
- Abbott said it will pay $385 million to resolve the claims and that there was no finding of fault or liability.
- Abbott said no unopened, distributed Abbott infant formulas have ever tested positive for Cronobacter sakazakii.
•
